UNSPSC 51101642: Calcium trisodium pentetate

This classification denotes a metal chelator with the molecular formula C14H18N3O10.Ca.3Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G79YN26H5B, chemically known as trisodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))calciate(3-) but generally known as calcium trisodium pentetate, which bears US NIH Compound Identifier 6328163. European Medicines Agency schedules Calcium trisodium pentetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13204MIG.

The term CALCIUM TRISODIUM PENTETATE is an International Non-Proprietary Name. Most nations schedule calcium trisodium pentetate under HS 29224995 and SITC 51465. SMILES: [Ca]12345OC(=O)CN4(CCN3(CCN5(CC(=O)O2)CC(=O)O)CC(=O)O)CC(=O)O1.[Na].[Na].[Na].

UNSPSC 51101642 Calcium trisodium pentetate is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and medical supplies procured through competitive bidding and cooperative purchasing vehicles. The recent opportunities posted under this code show state and local health agencies and counties sourcing antibiotics, opioid antagonists, and drug deactivation systems — purchases that diverge substantially from the code's nominal chemical name, indicating either broad tagging practices by issuing bodies or misclassification of health-commodity procurements. Issuing bodies include state health departments and county health authorities; the Illinois Department of Public Health and Seminole County, Florida appear as recent buyers. These entities typically procure through IFB (Invitation for Bid) processes, cooperative purchasing consortiums such as MMCAP Infuse, and piggyback contracts to access established supplier relationships at negotiated rates.

Recent activity concentrates in Florida and Illinois. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under MMCAP Infuse, totaling $2,999,999.11 over 12 months with two renewal options. Seminole County, Florida released an IFB on June 30, 2026 to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a July 26, 2023 response deadline, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford and including all shipping costs in vendor pricing. Both solicitations emphasize fixed-fee pricing, e-Procurement Portal submission, and standard compliance requirements including drug-free workplace certification and E-Verify.